Breast Cancer Patient Outcomes with Adjunctive Chinese Herbal Medicine Therapy

83 breast cancer patients were followed for 3–6 months in a prospective observational study comparing Western medicine alone to Western medicine plus adjunctive Chinese herbal medicine. The dataset, authored by Chien-Wei Tseng and last updated in April 2026, likely contains patient-reported outcomes on body constitution symptoms and quality of life, analyzed using inverse probability of treatment weighting and generalized estimating equation models.

Use Cases

• Modeling associations between adjunctive therapy and symptom improvement based on reported odds ratios for fatigue, dry eyes, and hot flushes.
• Analyzing longitudinal quality-of-life changes based on repeated measures from the WHOQOL-BREF instrument mentioned in the description.
• Studying real-world evidence for integrative cancer care based on the prospective observational cohort design.

Strengths

• Includes data from 83 patients followed for 3–6 months.
• Analysis employed statistical methods like inverse probability of treatment weighting and generalized estimating equations to address baseline imbalance.
• Released under a CC-BY-4.0 license, permitting reuse with attribution.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Causal inference cannot be established, as noted in the study conclusion.

Provenance

Source

figshare

Collection Method

Prospective observational study of a real-world breast cancer cohort.

Time Range

Study follow-up period of 3–6 months.

Freshness

Last updated 2026-04-20 04:11:54; freshness should be verified.

Geography

null